Remove Blog Remove Communication Remove Packaging
article thumbnail

New IFPMA and EFPIA guidance on use of social media by the pharmaceutical industry

pharmaphorum

The overarching principle set out in Codes of Practice, and in particular the Principles for the use of digital channels in the EFPIA Code , is that the legislation and Codes of Practice apply equally to communications by companies on social media and digital channels. However, the involvement of the company should always be stated.

article thumbnail

Navigating Regulatory Challenges in Pharma Marketing: Best Practices

Pharma Marketing Network

Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. In this blog post, we will explore best practices for pharmaceutical companies to navigate the complex landscape of regulatory challenges in marketing.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Mastering Responses to FDA 510(k) AI Letters: A Strategic Approach

The FDA Law Blog

In this blog post, we will first briefly outline the procedural steps in the 510(k) review process for medical devices. However, the strategy of addressing the AI request presented in the next section of this blog post applies to all three types of 510(k)s. FDA Day (in calendar days) FDA Actions Day 1 FDA receives 510(k) submission.

FDA 75
article thumbnail

Avastin Diary 8 – Vimto, Ice Cream and 7th Treatment

NF2 BioSolutions

There was a small mix up with communication that Oscar had bloods done at school, so we had a couple of messages saying they were doing it at home, when in fact they were doing it at school as usual during term time. This blog has been created as a way to share real stories, ideas, positivity and even sprinkle in some science.

article thumbnail

Smart pharmaceutical and healthcare labels: Lets trace medicines from its origin

Roots Analysis

In recent years, the use of smart labels allows the developer to convey a greater amount of information about the product to the consumers, without the need for additional packaging space. The post Smart pharmaceutical and healthcare labels: Lets trace medicines from its origin appeared first on Blog.

article thumbnail

eMDR System Enhancements

The FDA Law Blog

Background FDA first introduced the final rule and guidance on eMDR in 2014 , which we blogged about here. For any major changes, additional time will be granted between the release of the implementation package and production deployment. User facilities are not required, but have been encouraged, to submit MDRs electronically.

article thumbnail

Conference Notebook: ACI’s Cosmetics and Personal Care Products Conference

The FDA Law Blog

As readers of our blog know, MoCRA was a significant change to regulation of cosmetics. As the new law unfolds—and as state laws regarding ingredients and packaging, as well as laws regarding environmental claims continue to affect the cosmetics and personal care industries—the topics covered at the conference have never been more relevant.

FDA 64